Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug" ALT"Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug"July…

Continue ReadingBay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug

Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial" ALT"Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial"July 5, 2017By Mark Terry, BioSpace.com Breaking News... Source: BioSpace

Continue ReadingBristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial

3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-merger.jpg" NAME"Analyst: 3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven" ALT"Analyst: 3 Key Reasons Why a Gilead-Vertex Marriage May Not be…

Continue Reading3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven